Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27556254)

Published in Pediatr Pulmonol on August 24, 2016

Authors

Lacrecia J Britton1, Gabriela R Oates2, Robert A Oster2, Staci T Self3, Robert B Troxler3, Wynton C Hoover3, Hector H Gutierrez3, William T Harris4

Author Affiliations

1: Children's of Alabama Cystic Fibrosis Center, Birmingham, Alabama.
2: Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
3: Division of Pediatric Pulmonology, University of Alabama at Birmingham, Birmingham, Alabama.
4: Division of Pediatric Pulmonology, University of Alabama at Birmingham, Birmingham, Alabama. tharris@peds.uab.edu.

Articles cited by this

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol (2002) 4.85

Stress and health: major findings and policy implications. J Health Soc Behav (2010) 4.03

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol (1997) 3.23

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol (2001) 2.59

The developmental origins of chronic adult disease. Acta Paediatr Suppl (2004) 2.41

Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med (2002) 2.33

Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr (2009) 2.31

The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med (2001) 2.27

Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr (1998) 2.16

Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr (2003) 1.97

Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med (2000) 1.95

Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med (2009) 1.87

The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med (2013) 1.74

Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics (2007) 1.73

Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics (2007) 1.53

Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA (2008) 1.51

Median household income and mortality rate in cystic fibrosis. Pediatrics (2003) 1.46

Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.33

Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med (2008) 1.31

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med (2003) 1.29

Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J (2001) 1.27

Adult-type pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol (2000) 1.11

Paternal education status significantly influences infants' measles vaccination uptake, independent of maternal education status. BMC Public Health (2012) 1.09

Fathers of children and adolescents with diabetes: what do we know? J Pediatr Nurs (2008) 1.07

Bronchoscopy following diagnosis with cystic fibrosis. Arch Dis Child (2006) 0.99

Gender differences in the relationship of partner's social class to behavioural risk factors and social support in the Whitehall II study. Soc Sci Med (2004) 0.98

Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr (2005) 0.96

Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol (2001) 0.94

Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med (2002) 0.94

An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age. Ann Am Thorac Soc (2013) 0.92

Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med (2011) 0.92

Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation. Thorax (2005) 0.92

Racial discrepancies in the association between paternal vs. maternal educational level and risk of low birthweight in Washington State. BMC Pregnancy Childbirth (2004) 0.91

Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest (2013) 0.89

Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis. Pediatrics (2016) 0.86

Family Functioning and Treatment Adherence in Children and Adolescents with Cystic Fibrosis. Pediatr Allergy Immunol Pulmonol (2014) 0.85

Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc (2014) 0.85

Social disadvantage predicts growth outcomes in preadolescent children with cystic fibrosis. J Cyst Fibros (2008) 0.82

Father's education: an independent marker of risk for preterm birth. Matern Child Health J (2011) 0.80

Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes. Pediatr Pulmonol (2015) 0.79

Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics (2006) 0.79

Newborn screening for cystic fibrosis. Cochrane Database Syst Rev (2001) 0.79

Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc (2015) 0.78